Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Speciality MedicinesBOM:544738 -6.76%21 Interest Coverage is 9.54 as of Mar. 2026, which is 7% below its 10-year median of 10.24. GuruFocus rates BOM:544738 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 684 Drug Manufacturers companies, Speciality Medicines ranks worse than 55.7% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Speciality Medicines's
Operating Income
for the
six
months ended in Mar. 2026 was ₹82.6 Mil. Speciality Medicines's Interest Expense for the
six
months ended in Mar. 2026 was ₹-8.7 Mil.
Speciality Medicines's interest coverage for the quarter that ended in Mar. 2026 was 9.54.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Speciality Medicines's Interest Coverage or its related term are showing as below:
BOM:544738'
s Interest Coverage Range Over the Past 10 Years
Min: 8.34 Med: 10.24 Max: 103.72
Current: 9.54
BOM:544738's Interest Coverage is ranked worse than 55.7% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs BOM:544738: 9.54
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Speciality Medicines Interest Coverage Related Terms
Speciality Medicines Interest Coverage Historical Data
* Premium members only.
The historical data trend for Speciality Medicines's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Speciality Medicines Interest Coverage Chart
Speciality Medicines Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Interest Coverage
103.72
9.40
8.34
18.82
10.24
Speciality Medicines Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Interest Coverage
No Debt
N/A
N/A
19.46
9.54
BOM:544738 vs ZTS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Speciality Medicines's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Speciality Medicines Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Speciality Medicines's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Speciality Medicines's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Speciality Medicines (BOM:544738) has a Interest Coverage of 9.54 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Speciality Medicines and its competitors. This is near median its historical median of 10.24. Over the past decade, Speciality Medicines' Interest Coverage has ranged from 8.34 to 103.72. According to the industry distribution chart, Speciality Medicines ranks #381 out of 684 companies in the Drug Manufacturers industry, placing it in the top 55.7%.
Is Speciality Medicines' Interest Coverage too high?
Speciality Medicines' current Interest Coverage of 9.54 is near median its 10-year median of 10.24. Over the past 10 years, this metric has ranged from a low of 8.34 to a high of 103.72. The Drug Manufacturers industry median Interest Coverage is 12.77. Speciality Medicines' value of 9.54 is 25.3% below this industry median. Based on the distribution chart, Speciality Medicines ranks #381 out of 684 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Speciality Medicines has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Speciality Medicines' Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Speciality Medicines ranks #381 out of 684 companies for Interest Coverage. This places Speciality Medicines in the lower half of its industry. The industry median Interest Coverage is 12.77. Speciality Medicines' value of 9.54 is 25.3% below this benchmark. Historically, Speciality Medicines' own Interest Coverage has ranged from 8.34 to 103.72 over the past decade. While the company's 10-year median is 10.24 vs. the industry median of 12.77, Speciality Medicines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Speciality Medicines's current Interest Coverage of 9.54 is 25.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Speciality Medicines and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Speciality Medicines's current Interest Coverage is 9.54, which is near median its own 10-year median of 10.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Speciality Medicines stock overvalued right now?
Speciality Medicines (BOM:544738) has a current Interest Coverage of 9.54. The current Interest Coverage is 9.54, which is near median its 10-year median of 10.24 and 25.3% below the Drug Manufacturers industry median of 12.77. Speciality Medicines' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Speciality Medicines (BOM:544738), the current Interest Coverage is 9.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Speciality Medicines Ltd is engaged in the marketing and distribution of finished formulations of specialty pharmaceutical products, comprising oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. Its product range includes various dosage forms such as tablets, capsules, syrups, injections, infusions, inhalers, sprays, and topical formulations. The company operates through two business models: (a) Manufacturing, through contract manufacturing basis, and (b) Marketing and distribution of specialty pharmaceutical products sourced from manufacturers. The majority of the company's revenue is derived from the sale of its projects, mainly through exports to other countries.
21GF Score
Get the complete analysis for BOM:544738
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544738 has been successfully added to your 
